Literature DB >> 27362921

The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.

Aaron Langdon1, Bernd Grohe2.   

Abstract

The protein osteopontin (OPN) plays an important role in preventing the formation of calcium oxalate monohydrate (COM) kidney stones. To gain insight into these mechanisms, crystallization was induced by addition of human kidney OPN to artificial urine (ionic strength comparable to urine; without citrate), and the OPN-COM interaction studied using a combination of scanning electron (SEM) and confocal microscopy. By SEM, we found that increasing OPN concentrations formed large monoclinic penetration twins (no protein added) and, at higher concentrations (1-, 2μg/ml OPN), super and hyper twins with crystal habits not found in previous studies. For instance, the hyper twins indicate well-facetted gearwheel-like habits with "teeth" developed in all crystallographic <h0l> directions. At OPN concentrations ≥2μg/ml, a switching to small dumbbell-shaped COM habits with fine-textured surfaces occurred. Confocal microscopy of these dumbbells indicates protein incorporation in almost the entire crystal structure (in contrast to facetted COM), proposing a threshold concentration of ∼2μg/ml OPN for the facetted to the non-facetted habit transformation. Both the gearwheel-like and the dumbbell-shaped habit are again found side-by-side (presumably triggered by OPN concentration gradients within the sample) in in-vitro formed conglomerates, which resemble cross-sections of papillary kidney stones. The abrupt transformation from facetted to non-facetted habits and the unique compliance of the two in-vitro formed habits with the two main morphologies found in papillary kidney stones propose that OPN is a main effector in direct stone-forming processes. Moreover, stone structures which exhibit these two morphologies side-by-side might serve as a novel indicator for OPN concentrations surrounding those structures.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial urine; Calcium oxalate; Crystal morphology switching; Osteopontin; Papillary kidney stones; Physicochemical conditions; Protein incorporation

Mesh:

Substances:

Year:  2016        PMID: 27362921     DOI: 10.1016/j.colsurfb.2016.06.030

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.

Authors:  Jared S Gleberzon; Yinyin Liao; Silvia Mittler; Harvey A Goldberg; Bernd Grohe
Journal:  Urolithiasis       Date:  2018-12-19       Impact factor: 3.436

2.  Shape and structure controlling of calcium oxalate crystals by a combination of additives in the process of biomineralization.

Authors:  Nian Liu; Hao Xie; Hang Ping; Lin Wang; Zewen Liu; Fei Tao; Junhui Guo; Bao-Lian Su
Journal:  RSC Adv       Date:  2018-03-20       Impact factor: 4.036

Review 3.  Human kidney stones: a natural record of universal biomineralization.

Authors:  Mayandi Sivaguru; Jessica J Saw; Elena M Wilson; John C Lieske; Amy E Krambeck; James C Williams; Michael F Romero; Kyle W Fouke; Matthew W Curtis; Jamie L Kear-Scott; Nicholas Chia; Bruce W Fouke
Journal:  Nat Rev Urol       Date:  2021-05-24       Impact factor: 14.432

4.  The effects of HAP and macrophage cells to the expression of inflammatory factors and apoptosis in HK-2 cells of vitro co-cultured system.

Authors:  Junchuan Yu; Yaoliang Deng; Zhiwei Tao; Weixia Liang; Xiaofeng Guan; Jihua Wu; Xin Ning; Yunlong Liu; Quan Liu; Ziqi He
Journal:  Urolithiasis       Date:  2017-12-13       Impact factor: 3.436

5.  Comprehensive study of altered proteomic landscape in proximal renal tubular epithelial cells in response to calcium oxalate monohydrate crystals.

Authors:  Zhu Wang; Ming-Xing Li; Chang-Zhi Xu; Ying Zhang; Qiong Deng; Rui Sun; Qi-Yi Hu; Sheng-Ping Zhang; Jian-Wen Zhang; Hui Liang
Journal:  BMC Urol       Date:  2020-08-31       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.